World Health Organization (WHO)

Ongoing support for forgoing Rh testing in early pregnancy, medication abortion before six weeks, provider bias on contraceptive counseling adolescents, and local anesthesia before procedural abortion.

U.S. MEC and U.S. SPR, standard dosing of UPA EC for people of all body sizes, birth control information on TikTok, and safety of medication abortion without screening ultrasound.

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.

Trends in bHCG levels after medication abortion, a novel implant removal device, trends in IUD self-removal during the COVID-19 pandemic, and support for the patient-centeredness of telehealth birth control and abortion care.

Join the movement to make birth control pills available over the counter (OTC), without a prescription, in the drugstore right next to the condoms and lube.

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

Benefits of self-administered DMPA injections, an analysis of prophylactic pain management in medication abortion care, a need for ongoing education for providers on clinical indications for pelvic exams, the potential use of mifepristone as emergency contraception, and more.

Improved patient satisfaction with the implementation of One Key Question in primary care and OB/GYN care settings, increasing access to STI screening for adolescents and young adults, the need to improve contraceptive care for patients with a history of intimate partner violence, and more.